Fresh2 Group Limited

Equities

FRES

US03635R2067

Biotechnology & Medical Research

Delayed Nasdaq Other stock markets 01:23:12 2024-05-16 pm EDT			5-day change	1st Jan Change
0.4108 ^USD	+1.18%		-0.65%	-53.84%

Apr. 22	Fresh2 Group Receives Nasdaq Notice of Non-Compliance	MT
Mar. 21	ADRs Edge Higher; Lufax Climbs Almost 46%	DJ

Anpac Bio-Medical Science Co., Ltd. Appoints Chris Chang Yu as Co-CEO of the Company

May 09, 2022 at 07:31 am EDT

AnPac Bio-Medical Science Co., Ltd. announced effective May 7, 2022, the board of directors of the company appointed Dr. Chris Chang Yu, the former chief executive officer (the CEO) and former chairman of the board of the company as co-CEO of the company. Dr. Yu is a co-founder of the company and served as the chairman of the board and CEO from the company's inception in January 2010 until April 6, 2022.

Latest news about Fresh2 Group Limited

Fresh2 Group Receives Nasdaq Notice of Non-Compliance	Apr. 22	MT
ADRs Edge Higher; Lufax Climbs Almost 46%	Mar. 21	DJ
ADRs End Flat, Ehang Holdings Ltd. Climbs 15.6%	Mar. 19	DJ
Fresh2 Group Limited announced that it has received $13.512496 million in funding	Mar. 18	CI
ADRs End Flat, Fresh2 Group Ltd. Climbs 47.7%	Mar. 18	DJ
Fresh2 Group Ltd Launches TikTok Video E-commerce Venture, Bridging the Gap Between Food Sources and Consumers	Feb. 20	CI
ADRs Close Higher; Airnet Technology Climbs 54%	Feb. 15	DJ
Dollar slides versus yen as Japan warns against rapid fall	Feb. 14	RE
JGB yields track US peers up as investors weigh weak yen's impact on BOJ path	Feb. 14	RE
Dollar reigns as hot inflation cools Fed cut bets	Feb. 14	RE
Dollar reigns supreme as hot CPI cools bets for Fed cuts	Feb. 13	RE
ADRs Close Lower, Polestar Automotive Holding UK PLC Wt Declines 35.3%	Feb. 13	DJ
ADRs End Higher; Morphosys Climbs 56%	Feb. 05	DJ
Stocks strong, yields dip, this week's excitement still to come	Jan. 29	RE
ADRs End Lower; Evaxion Biotech A/S Drops 45%	Jan. 22	DJ
ADRs End Higher; The9 Climbs 16%	Jan. 19	DJ
ADRs End Lower, WISekey International Holding Ltd. Declines 17.3%	Jan. 17	DJ
ADRs Hold Steady; TDCX Inc. Climbs 30.4%	Jan. 03	DJ
ADRs Slump; FLJ Group Declines 21%	Jan. 02	DJ
ADRs Advance; Earlyworks Co. Ltd. Climbs 69.3%	Dec. 27	DJ
Fresh2 Group Limited Appoints Zhijun Liang as Independent Director, Effective January 1, 2024	Dec. 15	CI
UK's FTSE 100 hits over two-week high as miners shine	Dec. 01	RE
ADRs Slump, Connect Biopharma Holdings Ltd. Declines 38.8%	Nov. 21	DJ
Dollar poised to halt slide after Fed minutes	Nov. 21	RE
Euro zone bonds hold steady as ECB officials push back on early rate cut bets	Nov. 21	RE

Chart Fresh2 Group Limited

Duration

Period

More charts

Company Profile

Fresh2 Group Ltd, formerly AnPac Bio-Medical Science Co Ltd, is a biotechnology company mainly engaged in early cancer screening and detection. The Company is engaged in marketing and selling multi-cancer screening and detection test that uses cancer differentiation analysis (CDA), technology and its cancer-detection device or CDA device. The Company's CDA technology also assists physicians in cancer diagnosis, prognosis and recurrence. The Company provides a platform on which it has developed cancer screening and detection test using its CDA technology, or CDA test, and its CDA device. Its CDA technology focuses on biophysical properties in human blood. The Company is also engaged in providing technical solution and outsourcing consulting service focusing on the digital, Internet, and Web3 transformation of start-ups and traditional enterprises.

Sector

Biotechnology & Medical Research

Calendar

2024-05-22 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Bio Diagnostics & Testing

	1st Jan change	Capi.
FRESH2 GROUP LIMITED	-53.84%	9.02M
EXACT SCIENCES CORPORATION	-29.69%	9.84B
GUARDANT HEALTH, INC.	-0.15%	3.15B
IOVANCE BIOTHERAPEUTICS, INC.	+27.12%	2.99B
BGI GENOMICS CO., LTD.	-14.73%	2.15B
VERACYTE, INC.	-14.18%	1.8B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+69.92%	1.49B
CAREDX, INC	+23.33%	770M
SEEGENE, INC.	-2.84%	762M
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-22.86%	575M

Bio Diagnostics & Testing